2020 Half Year Results

The Group delivered a solid first-half financial performance with all three divisions growing revenue and patient volumes. The Company is pleased with the progress it has made in adapting the business to current healthcare trends and changing regulatory environments, especially at Hirslanden in Switzerland. At all three divisions, it continues to supplement its core acute care business through expansion across the healthcare continuum. The growth initiatives the Group is investing in, or collaborating on with partners, include day case clinics, primary care facilities, sub-acute hospitals, radiology, precision medicine, IVF and digital healthcare solutions.